AEterna Zentaris to Host Live Webcast of Analyst and Investor Meeting Today



    QUEBEC CITY, March 21 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ;
Nasdaq:   AEZS) announced that it will host a live webcast of the presentations
from its Analyst and Investor Day being held today beginning at 9:30 a.m.
(ET). AEterna Zentaris' management will present the Company's strategy as a
late-stage, pure play biopharmaceutical company, an update on the development
of its lead compounds cetrorelix, ozarelix and perifosine, as well as other
earlier-stage, promising product candidates.
    The live webcast of these presentations will be available on the
Company's website at www.aeternazentaris.com in the Investors section. A
replay will also be available for a period of 30 days.

    About AEterna Zentaris Inc.

    AEterna Zentaris Inc. is a late-stage, global biopharmaceutical company
focused on endocrine therapy and oncology with proven expertise in drug
discovery, development and commercialization.

    News releases and additional information are available at
    www.aeternazentaris.com.




For further information:

For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (418) 655-6420,
jenene.thomas@aeternazentaris.com; Paul Burroughs, Media Relations, (418)
652-8525 ext. 406, paul.burroughs@aeternazentaris.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890